Back

Chronic NLRP3 inflammasome activation drives neutrophil brain entry and interactions with microglia

Skuja, L. L.; Guldberg, S. M.; Joy, D.; Dugas, J. C.; Gould, N. S.; Chau, R.; Tatarakis, D.; Becerra, I.; Chau, C.; Ha, C.; Huynh, D.; Nguyen, H. N.; Sarrafha, L.; Sun, E. W.; Andrews, S. V.; Sandmann, T.; Suh, J. H.; Thorne, R. G.; Lein, P. J.; Monroe, K. M.; Di Paolo, G.

2026-04-23 neuroscience
10.64898/2026.04.22.720282 bioRxiv
Show abstract

NOD-like receptor family pyrin domain-containing 3 (NLRP3) is a cytosolic regulator of an inflammasome-mediated innate immune response. In the central nervous system (CNS), NLRP3 inflammasome activation has been implicated in multiple neurodegenerative diseases, yet the mechanisms by which it contributes to disease remain unclear. Here, we investigated the CNS effects of chronic NLRP3 activation using a humanized NLRP3 gain-of-function mouse model (hNLRP3D305N). Bulk brain analyses confirmed constitutive inflammasome activation, widespread cytokine induction, and the increased presence of blood-associated proteins suggestive of dysfunction at CNS border sites and the blood-brain barrier (BBB). Furthermore, cerebrospinal fluid (CSF) neurofilament light chain levels were elevated, indicating neuronal damage. Single-cell RNA-sequencing of CD45+ immune cells in the brain demonstrated that microglia adopt distinct reactive states and that peripheral immune cells infiltrate the CNS, with neutrophils emerging as the predominant infiltrating immune cell type. This finding was confirmed by untargeted bulk brain and CSF proteomics that also suggest neutrophil reactivity. Immunohistochemistry further revealed regional neutrophil entry into the brain parenchyma, concurrent with reactive microglia and engulfment of neutrophils, suggesting functional microglia-neutrophil interactions. Collectively, these findings establish a direct pathogenic role for the NLRP3 inflammasome in the CNS independent of other neurodegeneration-related disease pathologies.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Brain
154 papers in training set
Top 0.2%
18.3%
2
Journal of Neuroinflammation
50 papers in training set
Top 0.1%
9.9%
3
Nature Communications
4913 papers in training set
Top 23%
8.3%
4
Molecular Neurodegeneration
49 papers in training set
Top 0.1%
7.0%
5
Acta Neuropathologica
51 papers in training set
Top 0.2%
6.2%
6
Brain, Behavior, and Immunity
105 papers in training set
Top 0.5%
4.3%
50% of probability mass above
7
Neuron
282 papers in training set
Top 4%
3.5%
8
JCI Insight
241 papers in training set
Top 1%
3.5%
9
Cell Reports
1338 papers in training set
Top 17%
3.0%
10
Alzheimer's & Dementia
143 papers in training set
Top 2%
2.7%
11
Annals of Neurology
57 papers in training set
Top 0.8%
2.6%
12
Immunity
58 papers in training set
Top 2%
2.6%
13
Science Translational Medicine
111 papers in training set
Top 2%
2.0%
14
Nature Neuroscience
216 papers in training set
Top 4%
1.7%
15
eneuro
389 papers in training set
Top 6%
1.7%
16
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.6%
17
Neurobiology of Disease
134 papers in training set
Top 3%
1.2%
18
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 40%
0.9%
19
Molecular Psychiatry
242 papers in training set
Top 3%
0.9%
20
Advanced Science
249 papers in training set
Top 17%
0.9%
21
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.8%
22
iScience
1063 papers in training set
Top 33%
0.7%
23
eLife
5422 papers in training set
Top 59%
0.7%
24
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
25
Cell
370 papers in training set
Top 18%
0.7%
26
Science Advances
1098 papers in training set
Top 33%
0.6%